These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 14755376)

  • 21. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Kremer Hovinga JA; Studt JD; Lämmle B
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome.
    Lattuada A; Rossi E; Calzarossa C; Candolfi R; Mannucci PM
    Haematologica; 2003 Sep; 88(9):1029-34. PubMed ID: 12969811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma.
    Marques MB; Mayfield CA; Blackall DP
    Am J Clin Pathol; 2004 Jun; 121 Suppl():S89-96. PubMed ID: 15298154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Tsai HM
    J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Robertson MD; Zumberg M
    Am J Hematol; 2007 Mar; 82(3):224-8. PubMed ID: 17034025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
    Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B
    Semin Hematol; 2004 Jan; 41(1):75-82. PubMed ID: 14727262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Zhou Z; Nguyen TC; Guchhait P; Dong JF
    Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thrombotic thrombocytopenic purpura in children -- pathophysiologic mechanisms and their clinical significance].
    Korczowski B
    Med Wieku Rozwoj; 2005; 9(4):753-61. PubMed ID: 16733283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.
    Peyvandi F; Ferrari S; Lavoretano S; Canciani MT; Mannucci PM
    Br J Haematol; 2004 Nov; 127(4):433-9. PubMed ID: 15521921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thrombotic microangiopathy: thrombocytopenia and hemolytic anemia].
    Kater AP; van der Lelie J; Levi M
    Ned Tijdschr Geneeskd; 2002 Dec; 146(49):2343-7. PubMed ID: 12510396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thrombotic thrombocytopenic purpura. Reduced activity of von Willebrand factor cleaving protease].
    Kunze A; Terborg C; Gerth J; Heide G; Witte OW
    Nervenarzt; 2004 Aug; 75(8):785-9. PubMed ID: 15034657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypersensitivity to plasma exchange in a patient with thrombotic thrombocytopenic purpura.
    Lalmuanpuii J; Yalamanchili K; Fircanis S; Nelson JC
    J Clin Apher; 2009; 24(1):18-20. PubMed ID: 19073012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Solenthaler M; Wassmer M; Sandoz P; Lämmle B
    Blood; 1997 May; 89(9):3097-103. PubMed ID: 9129011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy for thrombotic thrombocytopenic purpura.
    Cataland SR; Wu HM
    Curr Opin Hematol; 2005 Sep; 12(5):359-63. PubMed ID: 16093780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
    Saha M; McDaniel JK; Zheng XL
    J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New marker in thrombotic thrombocytopenic purpura].
    Gøtze JP; Hillarp A; Lindblom A; Björk P; Strandberg K; Nielsen LB
    Ugeskr Laeger; 2008 Aug; 170(33):2446-9. PubMed ID: 18761827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of ADAMT-13 in platelet adhesion in flow: methods for diagnosis of thrombotic thrombocytopenic purpura.
    Shenkman B
    Pathophysiol Haemost Thromb; 2006; 35(1-2):98-102. PubMed ID: 16855353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.